The size of the Global HIV Diagnostics Market was worth USD 2.61 Billion in 2019 and is estimated to be growing at a CAGR of 9.5%, to reach USD 4.11 Billion by 2024 during the forecast period.
The human immunodeficiency virus (HIV) infection refers to a kind of retrovirus that causes (AIDS). HIV affects some immune cells, and it weakens the immune system bringing about loss of capacity to fight against the organisms that cause diseases.
Industry Growth Drivers
Major Challenges
Industry Overview
According to WHO, people diagnosing with HIV reaching millions, out of which few millions of people die every year. AIDS is the advance stage of HIV which affects the immune system. People whose CD4 cells are lower than 200/mm are diagnosing as AIDS patients. This HIV test uses samples of blood, serum or urine where blood samples give accurate diagnosis result.
In India, the AIDS control programme has got a success story. The FDA has accepted the test to diagnose the HIV Type1 drug resistance using NGS, i.e., next-generation sequencing.
However, the governments across the world have conducted campaigns, educational seminars in colleges, corporate places, and other public places to bring awareness to people. Recently Kenya Medical Research Institute has introduced its new Cobas Plasma Separation Card to collect samples and to test them in a short period.
Key Happenings in this Market in the Recent Past:
REPORT COVERAGE
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2018 – 2024 |
|
Base Year |
2018 |
|
Forecast Period |
2019 - 2024 |
|
Segments Covered |
By Product, Type, Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, APAC, Latin America, Middle East & Africa |
This market research report on the Global HIV Diagnostics Market has been segmented and sub-segmented based on the product type, test type, end-user and region.
By Product
Based on the product, the consumables segment is contributing a significant share to the global HIV diagnostics market. Factors like the increasing incidence of HIV and AIDS as most of the hospitals and laboratories; governments of various countries have started working aggressively to control HIV/AIDS boosting the usage of consumables.
By Test Type
Based on type, the Antibody tests segment is dominating the market growth and continue its trend during the forecast period. The factors that are contributing to the growth of this segment are increasing account of blood donations, raising awareness of HIV and Aids among people, the emergence of novel and innovative medical practices owing to technological advancements.
By End-User
Based on end-user, the diagnostic laboratories segment is dominating the global HIV Diagnostics market owing to factors such as spreading awareness about HIV and AIDS among the people in developing countries. Further, the increasing focus of private and government organizations to incline investments in developing advanced diagnostic laboratories with technologically advanced equipment and diagnostic techniques.
Regional Analysis
The Global HIV Diagnostics Market was dominated by North America, with the overall market share of over 38% globally. North America was followed by Asia pacific. The Asia Pacific to grow at a rapid pace in the coming few years, because of its high unmet demand in India and China.
North America to dominate the HIV Diagnostics Market with the most significant shares. Rising incidences of various health diseases and growing demand for the development of novel drugs are significant factors propelling the application of the market in this region. Increasing awareness among people, government initiatives to prevent HIV, widening of research and development of health facilities are also the reason for the growth in the North America region.
Europe and Asia-Pacific regions are following North America and are likely to have the highest share during the period. Increase in disposable income and recently developed healthcare equipment to propel the demand of the market. Countries like India and China are playing significant roles in contributing the highest shares for the market.
The Middle East and Africa region are to have a slow-growth due to lack of knowledge among the people. In this region, South Africa has the highest HIV prevalent.
List of key market participants leading the Global HIV Diagnostics Market profiled in this report:
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Consumables
5.1.2.1 Assays and Kits &Reagents
5.1.2.2 Other Consumables
5.1.3 Instruments
5.1.4 Software & Services
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 Type
5.2.1 Introduction
5.2.2 Antibody Tests
5.2.2.1 HIV Screening Tests
5.2.2.1.1 Elisa
5.2.2.1.2 Rapid Tests
5.2.2.1.3 Home Access Dried Blood Spots
5.2.2.2 HIV-1 Antibody Confirmatory Tests
5.2.2.2.1 Western Blot Tests
5.2.2.2.2 Indirect Immunofluorescence Assays (IFA)
5.2.2.2.3 Line Immunoassays
5.2.2.2.4 Radio-Immunoprecipitation Assays
5.2.2.3 HIV-2 & Group O Diagnostic Tests
5.2.2.3.1 Blood Antibody Tests
5.2.2.3.2 DBS Tests
5.2.2.3.3 Line ImmunoAssay (HIV2)
5.2.3 Viral Identification Tests
5.2.3.1 p24 Antigen Test
5.2.3.2 Qualitative PCR Tests
5.2.3.3 Viral Culture
5.2.4 CD4 Testing
5.2.5 Viral Load testing
5.2.6 Early Infant Diagnostics
5.2.7 Y-o-Y Growth Analysis, By Type
5.2.8 Market Attractiveness Analysis, By Type
5.2.9 Market Share Analysis, By Type
5.3 End User
5.3.1 Introduction
5.3.2 Diagnostic Laboratories
5.3.3 Hospitals
5.3.4 Blood Banks
5.3.5 Home Care Settings
5.3.6 Other End Users
5.3.7 Y-o-Y Growth Analysis, By End User
5.3.8 Market Attractiveness Analysis, By End User
5.3.9 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Type
6.1.3.4 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Type
6.1.4.4 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Type
6.1.5.4 By End User
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Siemens Healthineers (A Division of Siemens AG)
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Roche Diagnostics (Division of Hoffman La Roche Ltd.)
8.3 Abbott Laboratories
8.4 Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
8.5 Thermo-Fisher Scientific Inc.
8.6 Merck KGaA
8.7 Becton, Dickinson & Company
8.8 Hologic Inc.
8.9 Alere Inc.
8.10 Bio-Rad Laboratories
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
